None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Patients of either sex in the age group between 25 to 60 years • LDL levels (>=130 mg/dL and • Patient with body mass index of >= 23 kg/m2 and • Untreated Dyslipidemia • Willingness to maintain current activity levels and follow the prescribed diet
Exclusion criteria
Exclusion criteria: • Use of oral or injected corticosteroids or anabolic steroids at Visit 1 or prior to randomization • Uncontrolled hypothyroidism • Poorly controlled hypertension (resting blood pressure >=160 mm Hg systolic and/or >=100 mm Hg diastolic) • Participants on Medication/special diets for weight loss • Current smoker • Recent history (past 12 months) of drug abuse or alcohol abuse. Alcohol abuse will be defined as >14 drinks per week. • Exposure to any investigational product within 4 weeks prior to Visit 1, or prior to randomization • Women who are pregnant, lactating, or planning to become pregnant • Liver disorders • Taking lipid lowering drugs • Congestive cardiac failure, acute myocardial infarction within last 1 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of Interesterified dietary fat on Optimal weight management.Timepoint: 45 Days from Baseline Visit | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of Interesterified dietary fat on following parameters: â?¢ Calorie content of food and Stool energy loss Total cholesterol, LDL-Cholesterol, HDL-Cholesterol and Triglycerides. â?¢ Body Mass Index, Body composition i.e. Fat mass, Fat free mass, Body fat (%) and Body Adiposity Index. â?¢ C-Peptide, Glucose (Random) and Insulin. â?¢ Leptin and Adiponectin.Timepoint: 45 Days from Baseline Visit | — |
Countries
India
Contacts
Spectrum Clinical Research Pvt. Ltd.